Obesity in Canada is a growing health concern, which is "expected to surpass smoking as the leading cause of preventable morbidity and mortality … and represents a burden of Can$3.96 (US$4.16/€2.85) billion on the Canadian economy each year.
Canadian waistlines are expanding, and the global recession is partly to blame, according to a new report from the Organization for Economic Cooperation and Development.
The latest findings show 25 per cent of adult Canadians are obese. That's higher than the average rate of obesity among OECD countries (18 per cent). Still, the report notes Canada's rate of increase is one of the slowest in the group of 34 countries.
Children in Canada registered the same obesity rate as their adult counterparts — also higher than the OECD average.

The first National Obesity Summit was held May 7–10 at the Delta Lodge in Kananaskis, Alberta. This was Canada's first "all-obesity" meeting and was a huge success. Almost 500 delegates attended the conference, which surpassed the venues capacity. Researchers, practitioners and other stakeholders from a wide range of disciplines and interests came to Kananaskis to share with and learn from their peers in a unique and interactive environment. The oral presentations, poster sessions, workshops and seminars represented a fascinating cross-section of thought and novel findings on many of the key issues in obesity today. Plenary Sessions included: 1) Obesity and Mental Health, 2) Behavioural and Biological Determinants of Obesity, 3) Obesity Management and 4) Health Economics & Policy of Obesity. Please see the final programme for further details.

The 4th National Obesity Summit will take place in Toronto, Ontario from April 28 - May 2, 2015

There are many lap band clinics in Canada. The challenge is what's next?

The next technologies are:

When diet, exercise and pills dont work, patients will try products that are inserted via mouth into the stomach by a GI doctor. The products can be intra-gastric balloon which is a glorified breast implant stuffed in the stomach to fill the stomach. Patients can lose up to 20 lb to 30 lb in period of 6 months. This implant has to be removed after 6 months. Patients typically gain the weight back.

The makers of the balloon include: Reshape Medical, Obalon and Apollo.

Other technologies include a plastic liner that lines the intestines called endobarrier. A Gi doctor is trained to insert this product. One of the popular procedure is called endo-barrier which is made by GiDynamics.

Bariatric surgeons are not trained GI doctors so conducting procedure via mouth can put their practices at risk in the US. Outside US doctors can cross train, but respective medical specialty associations want to reserve the technique for themselves.. triggering a turf war.

Gi doctors are not laparoscopic surgeons so cannot insert a gastric band.

Similarly, plastic surgeons are not qualified bariatric surgeons or obesity surgeons and therefore cannot treat obese patients with gastric band technology. Gastric band is reversible technology that acts like a speed breaker for food consumption. Gastric band is approved by the US FDA for bariatric surgeons. The device is a silicone implant that is tied around the top portion of the stomach. Patients are known to lose weight over time and if not complied to, can lead to weight regain. The companies that make a gastric band is: Apollo and J&J

There are some versions of this technology called the Minimizer ring.

Bariatric surgeons or obesity surgeons are also qualified to use a device called endo-stapler. This device staples and cuts tissue at the same time.

Staplers are made by two companies: J&J and Covidien. Both companies are leaders in obesity space.

A surgeon will cut portions of the stomach and intestines and remove it permanently. The procedure is called Gastric bypass and Sleeve gastrectomy. "tomy" means "CUT". It sounds terrible, but believe it or not, bariatric surgery is the most effective form. Also the most lucrative for surgeons.

Recently, new reversible technology promises to imitate gastric surgery without cutting portions of the stomach is gaining popularity. Product is called Gastric Vest System made by a company called Onciomed. Typically, technologies like the gastric band and the GVS are taken over by one of the large companies even before it can hit the market. The GVS product is in clinical trials in Latin America.

As the turf battle for obesity patients increases between GI doctors and Bariatric Surgeons. There is another quite battle raging between the large players wanting to be in the obesity space. These large companies are waiting for the oven to bake new technologies, ready or not these technologies will be acquired at a large premium. These new technology products are acquired to refresh the pipeline and capture market share or make a new entry into the obesity market.

Surprise players in this space could be: Medtronic and Boston Scientific . Medtronic has recently announced purchase of Covidien which is a maker of stapler technology, laparascopic instruments and has history of distributing gastric bands. Medtronic can play a big role in acquiring new technologies. It spends Billions of dollars to acquire new technologies.

Boston Sci recent history of swift acquisitions suggest that its aggressive acquisition strategy can lead them to become leaders in innovative technologies. Something J&J needs to worry about. Other nimble players can be Bard, Teleflex, Gore and even drug companies.

Allergan a drug manufacturer purchased the maker of Lap Band and did well.

Obesity was recently identified as a disease by AMA and since them the large and small players in the drug, device industry are scrambling to take a spot in the innovation space. Even FDA and international regulatory agencies are easing the approval process for such product that can help patients and reduce the burden on the health care system.

VCs and investors who were on the sidelines are starting to jump in. Several VCs were burnt with poor performance of Satiety and Vibrynt, Inc. Both technology had limitations and adoption issues.

VCs are putting that experience behind them, some VC firms have raised new money and are looking to invest in obesity. Suddenly, investors realize that obesity companies can offer multi X returns.

Several companies have lined up new products. My favorite amongst obesity innovations are:

Obesity Drug: Vivus Pharmaceutical Inc

Obesity Device for GI doctors: GiDynamics, Inc

Obesity Device for Bariatric Surgeons: Onciomed, Inc

Disclaimer: I do not have financial interest in any of the above companies. I independently evaluate companies that can help patients.

When diet, exercise and pills dont work, patients will try products that are inserted via mouth into the stomach by a GI doctor. The products can be intra-gastric balloon which is a glorified breast implant stuffed in the stomach to fill the stomach. Patients can lose up to 20 lb to 30 lb in period of 6 months. This implant has to be removed after 6 months. Patients typically gain the weight back.

The makers of the balloon include: Reshape Medical, Obalon and Apollo.

Other technologies include a plastic liner that lines the intestines called endobarrier. A Gi doctor is trained to insert this product. One of the popular procedure is called endo-barrier which is made by GiDynamics.

Bariatric surgeons are not trained GI doctors so conducting procedure via mouth can put their practices at risk in the US. Outside US doctors can cross train, but respective medical specialty associations want to reserve the technique for themselves.. triggering a turf war.

Gi doctors are not laparoscopic surgeons so cannot insert a gastric band.

Similarly, plastic surgeons are not qualified bariatric surgeons or obesity surgeons and therefore cannot treat obese patients with gastric band technology. Gastric band is reversible technology that acts like a speed breaker for food consumption. Gastric band is approved by the US FDA for bariatric surgeons. The device is a silicone implant that is tied around the top portion of the stomach. Patients are known to lose weight over time and if not complied to, can lead to weight regain. The companies that make a gastric band is: Apollo and J&J

There are some versions of this technology called the Minimizer ring.

Bariatric surgeons or obesity surgeons are also qualified to use a device called endo-stapler. This device staples and cuts tissue at the same time.

Staplers are made by two companies: J&J and Covidien. Both companies are leaders in obesity space.

A surgeon will cut portions of the stomach and intestines and remove it permanently. The procedure is called Gastric bypass and Sleeve gastrectomy. "tomy" means "CUT". It sounds terrible, but believe it or not, bariatric surgery is the most effective form. Also the most lucrative for surgeons.

Recently, new reversible technology promises to imitate gastric surgery without cutting portions of the stomach is gaining popularity. Product is called Gastric Vest System made by a company called Onciomed. Typically, technologies like the gastric band and the GVS are taken over by one of the large companies even before it can hit the market. The GVS product is in clinical trials in Latin America.

As the turf battle for obesity patients increases between GI doctors and Bariatric Surgeons. There is another quite battle raging between the large players wanting to be in the obesity space. These large companies are waiting for the oven to bake new technologies, ready or not these technologies will be acquired at a large premium. These new technology products are acquired to refresh the pipeline and capture market share or make a new entry into the obesity market.

Surprise players in this space could be: Medtronic and Boston Scientific . Medtronic has recently announced purchase of Covidien which is a maker of stapler technology, laparascopic instruments and has history of distributing gastric bands. Medtronic can play a big role in acquiring new technologies. It spends Billions of dollars to acquire new technologies.

Boston Sci recent history of swift acquisitions suggest that its aggressive acquisition strategy can lead them to become leaders in innovative technologies. Something J&J needs to worry about. Other nimble players can be Bard, Teleflex, Gore and even drug companies.

Allergan a drug manufacturer purchased the maker of Lap Band and did well.

Obesity was recently identified as a disease by AMA and since them the large and small players in the drug, device industry are scrambling to take a spot in the innovation space. Even FDA and international regulatory agencies are easing the approval process for such product that can help patients and reduce the burden on the health care system.

VCs and investors who were on the sidelines are starting to jump in. Several VCs were burnt with poor performance of Satiety and Vibrynt, Inc. Both technology had limitations and adoption issues.

VCs are putting that experience behind them, some VC firms have raised new money and are looking to invest in obesity. Suddenly, investors realize that obesity companies can offer multi X returns.

Several companies have lined up new products. My favorite amongst obesity innovations are:

Obesity Drug: Vivus Pharmaceutical Inc

Obesity Device for GI doctors: GiDynamics, Inc

Obesity Device for Bariatric Surgeons: Onciomed, Inc

Disclaimer: I do not have financial interest in any of the above companies. I independently evaluate companies that can help patients.

- See more at: http://medicaldeviceipo.blogspot.com/search?updated-min=2014-01-01T00:00:00-08:00&updated-max=2015-01-01T00:00:00-08:00&max-results=18#sthash.J5RlRFCt.dpuf

When diet, exercise and pills dont work, patients will try products that are inserted via mouth into the stomach by a GI doctor. The products can be intra-gastric balloon which is a glorified breast implant stuffed in the stomach to fill the stomach. Patients can lose up to 20 lb to 30 lb in period of 6 months. This implant has to be removed after 6 months. Patients typically gain the weight back.

The makers of the balloon include: Reshape Medical, Obalon and Apollo.

Other technologies include a plastic liner that lines the intestines called endobarrier. A Gi doctor is trained to insert this product. One of the popular procedure is called endo-barrier which is made by GiDynamics.

Bariatric surgeons are not trained GI doctors so conducting procedure via mouth can put their practices at risk in the US. Outside US doctors can cross train, but respective medical specialty associations want to reserve the technique for themselves.. triggering a turf war.

Gi doctors are not laparoscopic surgeons so cannot insert a gastric band.

Similarly, plastic surgeons are not qualified bariatric surgeons or obesity surgeons and therefore cannot treat obese patients with gastric band technology. Gastric band is reversible technology that acts like a speed breaker for food consumption. Gastric band is approved by the US FDA for bariatric surgeons. The device is a silicone implant that is tied around the top portion of the stomach. Patients are known to lose weight over time and if not complied to, can lead to weight regain. The companies that make a gastric band is: Apollo and J&J

There are some versions of this technology called the Minimizer ring.

Bariatric surgeons or obesity surgeons are also qualified to use a device called endo-stapler. This device staples and cuts tissue at the same time.

Staplers are made by two companies: J&J and Covidien. Both companies are leaders in obesity space.

A surgeon will cut portions of the stomach and intestines and remove it permanently. The procedure is called Gastric bypass and Sleeve gastrectomy. "tomy" means "CUT". It sounds terrible, but believe it or not, bariatric surgery is the most effective form. Also the most lucrative for surgeons.

Recently, new reversible technology promises to imitate gastric surgery without cutting portions of the stomach is gaining popularity. Product is called Gastric Vest System made by a company called Onciomed. Typically, technologies like the gastric band and the GVS are taken over by one of the large companies even before it can hit the market. The GVS product is in clinical trials in Latin America.

As the turf battle for obesity patients increases between GI doctors and Bariatric Surgeons. There is another quite battle raging between the large players wanting to be in the obesity space. These large companies are waiting for the oven to bake new technologies, ready or not these technologies will be acquired at a large premium. These new technology products are acquired to refresh the pipeline and capture market share or make a new entry into the obesity market.

Surprise players in this space could be: Medtronic and Boston Scientific . Medtronic has recently announced purchase of Covidien which is a maker of stapler technology, laparascopic instruments and has history of distributing gastric bands. Medtronic can play a big role in acquiring new technologies. It spends Billions of dollars to acquire new technologies.

Boston Sci recent history of swift acquisitions suggest that its aggressive acquisition strategy can lead them to become leaders in innovative technologies. Something J&J needs to worry about. Other nimble players can be Bard, Teleflex, Gore and even drug companies.

Allergan a drug manufacturer purchased the maker of Lap Band and did well.

Obesity was recently identified as a disease by AMA and since them the large and small players in the drug, device industry are scrambling to take a spot in the innovation space. Even FDA and international regulatory agencies are easing the approval process for such product that can help patients and reduce the burden on the health care system.

VCs and investors who were on the sidelines are starting to jump in. Several VCs were burnt with poor performance of Satiety and Vibrynt, Inc. Both technology had limitations and adoption issues.

VCs are putting that experience behind them, some VC firms have raised new money and are looking to invest in obesity. Suddenly, investors realize that obesity companies can offer multi X returns.

Several companies have lined up new products. My favorite amongst obesity innovations are:

Obesity Drug: Vivus Pharmaceutical Inc

Obesity Device for GI doctors: GiDynamics, Inc

Obesity Device for Bariatric Surgeons: Onciomed, Inc

Disclaimer: I do not have financial interest in any of the above companies. I independently evaluate companies that can help patients.

- See more at: http://medicaldeviceipo.blogspot.com/search?updated-min=2014-01-01T00:00:00-08:00&updated-max=2015-01-01T00:00:00-08:00&max-results=18#sthash.J5RlRFCt.dpuf

Saturday, September 6, 2014

Obesity Epidemic in Canada 2014: Demands for treaments create new market for new obesity technologies and innovations

The makers of the balloon include: Reshape Medical, Obalon and Apollo.

Other technologies include a plastic liner that lines the intestines called endobarrier. A Gi doctor is trained to insert this product. One of the popular procedure is called endo-barrier which is made by GiDynamics.

Bariatric surgeons are not trained GI doctors so conducting procedure via mouth can put their practices at risk in the US. Outside US doctors can cross train, but respective medical specialty associations want to reserve the technique for themselves.. triggering a turf war.

Gi doctors are not laparoscopic surgeons so cannot insert a gastric band.

There are some versions of this technology called the Minimizer ring.

Bariatric surgeons or obesity surgeons are also qualified to use a device called endo-stapler. This device staples and cuts tissue at the same time.

Staplers are made by two companies: J&J and Covidien. Both companies are leaders in obesity space.

A surgeon will cut portions of the stomach and intestines and remove it permanently. The procedure is called Gastric bypass and Sleeve gastrectomy. "tomy" means "CUT". It sounds terrible, but believe it or not, bariatric surgery is the most effective form. Also the most lucrative for surgeons.

Boston Sci recent history of swift acquisitions suggest that its aggressive acquisition strategy can lead them to become leaders in innovative technologies. Something J&J needs to worry about. Other nimble players can be Bard, Teleflex, Gore and even drug companies.

Allergan a drug manufacturer purchased the maker of Lap Band and did well.

VCs and investors who were on the sidelines are starting to jump in. Several VCs were burnt with poor performance of Satiety and Vibrynt, Inc. Both technology had limitations and adoption issues.

VCs are putting that experience behind them, some VC firms have raised new money and are looking to invest in obesity. Suddenly, investors realize that obesity companies can offer multi X returns.

Several companies have lined up new products. My favorite amongst obesity innovations are:

Obesity Drug: Vivus Pharmaceutical Inc

Obesity Device for GI doctors: GiDynamics, Inc

Obesity Device for Bariatric Surgeons: Onciomed, Inc

Disclaimer: I do not have financial interest in any of the above companies. I independently evaluate companies that can help patients.

The makers of the balloon include: Reshape Medical, Obalon and Apollo.

Other technologies include a plastic liner that lines the intestines called endobarrier. A Gi doctor is trained to insert this product. One of the popular procedure is called endo-barrier which is made by GiDynamics.

Bariatric surgeons are not trained GI doctors so conducting procedure via mouth can put their practices at risk in the US. Outside US doctors can cross train, but respective medical specialty associations want to reserve the technique for themselves.. triggering a turf war.

Gi doctors are not laparoscopic surgeons so cannot insert a gastric band.

There are some versions of this technology called the Minimizer ring.

Bariatric surgeons or obesity surgeons are also qualified to use a device called endo-stapler. This device staples and cuts tissue at the same time.

Staplers are made by two companies: J&J and Covidien. Both companies are leaders in obesity space.

A surgeon will cut portions of the stomach and intestines and remove it permanently. The procedure is called Gastric bypass and Sleeve gastrectomy. "tomy" means "CUT". It sounds terrible, but believe it or not, bariatric surgery is the most effective form. Also the most lucrative for surgeons.

Boston Sci recent history of swift acquisitions suggest that its aggressive acquisition strategy can lead them to become leaders in innovative technologies. Something J&J needs to worry about. Other nimble players can be Bard, Teleflex, Gore and even drug companies.

Allergan a drug manufacturer purchased the maker of Lap Band and did well.

VCs and investors who were on the sidelines are starting to jump in. Several VCs were burnt with poor performance of Satiety and Vibrynt, Inc. Both technology had limitations and adoption issues.

VCs are putting that experience behind them, some VC firms have raised new money and are looking to invest in obesity. Suddenly, investors realize that obesity companies can offer multi X returns.

Several companies have lined up new products. My favorite amongst obesity innovations are:

Obesity Drug: Vivus Pharmaceutical Inc

Obesity Device for GI doctors: GiDynamics, Inc

Obesity Device for Bariatric Surgeons: Onciomed, Inc

Disclaimer: I do not have financial interest in any of the above companies. I independently evaluate companies that can help patients.

The makers of the balloon include: Reshape Medical, Obalon and Apollo.

Other technologies include a plastic liner that lines the intestines called endobarrier. A Gi doctor is trained to insert this product. One of the popular procedure is called endo-barrier which is made by GiDynamics.

Bariatric surgeons are not trained GI doctors so conducting procedure via mouth can put their practices at risk in the US. Outside US doctors can cross train, but respective medical specialty associations want to reserve the technique for themselves.. triggering a turf war.

Gi doctors are not laparoscopic surgeons so cannot insert a gastric band.

There are some versions of this technology called the Minimizer ring.

Bariatric surgeons or obesity surgeons are also qualified to use a device called endo-stapler. This device staples and cuts tissue at the same time.

Staplers are made by two companies: J&J and Covidien. Both companies are leaders in obesity space.

A surgeon will cut portions of the stomach and intestines and remove it permanently. The procedure is called Gastric bypass and Sleeve gastrectomy. "tomy" means "CUT". It sounds terrible, but believe it or not, bariatric surgery is the most effective form. Also the most lucrative for surgeons.

Boston Sci recent history of swift acquisitions suggest that its aggressive acquisition strategy can lead them to become leaders in innovative technologies. Something J&J needs to worry about. Other nimble players can be Bard, Teleflex, Gore and even drug companies.

Allergan a drug manufacturer purchased the maker of Lap Band and did well.

VCs and investors who were on the sidelines are starting to jump in. Several VCs were burnt with poor performance of Satiety and Vibrynt, Inc. Both technology had limitations and adoption issues.

VCs are putting that experience behind them, some VC firms have raised new money and are looking to invest in obesity. Suddenly, investors realize that obesity companies can offer multi X returns.

Several companies have lined up new products. My favorite amongst obesity innovations are:

Obesity Drug: Vivus Pharmaceutical Inc

Obesity Device for GI doctors: GiDynamics, Inc

Obesity Device for Bariatric Surgeons: Onciomed, Inc

Disclaimer: I do not have financial interest in any of the above companies. I independently evaluate companies that can help patients.

No comments:

Post a Comment